ABERRANT P53 EXPRESSION IS THE STRONGEST PREDICTOR FOR NEOPLASTIC PROGRESSION IN PATIENTS WITH BARRETT’S ESOPHAGUS
Pauline Zellenrath 1
Judith Honing 1
Pieter Jan de Jonge 1
Arjun D. Koch 1
Manon C.W. Spaander 1
1 Erasmus University Medical Center, Rotterdam, Netherlands
Topic
Oesophagus
Conference
UEG Week 2023
Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]